Limula
Lausanne, CH · 6 known investors
Find your way into Limula
831 people in our graph share verified history with the Limula team — schools, employers, funds. One of them is your warm intro.
Jen Wangunlockedknows Thomas Eaton · together at UBS (overlapped)
×4knows the team · via University of Oxford
knows the team · via San Diego State University
knows the team · via UBS
knows the team · via University of Geneva
knows the team · via Ecole polytechnique fédérale de Lausanne
Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes. It serves cell therapy developers and manufacturers in the biotech and pharmaceutical industry, and is based in Switzerland.
Founders & leadership
TE
Thomas EatoninFounder & CEOThomas Eaton previously worked as a consultant and held an academic position at Oxford. He is Founder and CEO of Limula, a Switzerland-based company developing an automated platform for manufacturing cell and gene therapies.
YP
Yann PiersoninFounder & CTOYann Pierson holds a DPhil in Chemical Biology from the University of Oxford and previously served as a scientific advisor to EPFL's president. He co-founded Limula in 2020, where he has led the company and secured CHF 22 million in combined equity and non-dilutive funding.
CB
Caroline BoudousquiéinHead of Solutions
OW
Olivier WaridelinHead of OperationsWith over two decades of international business experience across Europe, North America, South America, and Asia, he has held roles in business development, product innovation, marketing, sales, quality, regulatory compliance, and general management.
Investors · 6
LifeX Ventures✓ verifiedSan Franciscovia Inaki Berenguer · inferred
.jpeg){kind=logo}
Verve VenturesZug · $1.1M – $2.2M
Zühlke VenturesZurich · $165K – $275K
Oxford Seed Fundreported · 2 sourcesOxford · $19.1K – $127K
Also in the syndicate · 2
Lichtsteiner FoundationW.A. de Vigier Foundation
Funding
SEC filings, press & company announcements$6.8M disclosed across 1 of 3 rounds · 2024
- $6.8Mseed roundMay 2024 · 3 sources
LifeX Ventures (lead), Lichtsteiner Foundation, Oxford Seed Fund, Verve Ventures, W.A. de Vigier Foundation, Zühlke Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Limula do?
- Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes. It serves cell therapy developers and manufacturers in the biotech and pharmaceutical industry, and is based in Switzerland.
- Who founded Limula?
- Limula was founded by Thomas Eaton, Yann Pierson.
- Who are Limula's investors?
- Limula's investors include LifeX Ventures, Verve Ventures, Zühlke Ventures, Oxford Seed Fund.
- How much funding has Limula raised?
- Limula has disclosed $6.8M raised across 1 of its 3 known rounds.
- Where is Limula headquartered?
- Limula is headquartered in Lausanne, CH.